Pertti J. Pentikäinen

Author

Also Known As

PERTTI PENTIKAINEN, Pertti J Pentikäinen, Pertti J. Pentikainen, Pertti J. Pentikäinen, Pertti Pentikainen, Pertti Pentikäinen

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

University of Helsinki Helsinki University Hospital Orion Corporation (Finland)University of Kansas Medical Center Kuopio University Hospital

About

Pertti J. Pentikäinen is an author at University of Helsinki specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	692
2	Health Sciences	3	3	62
3	Biochemistry	3	3	56
4	Endocrinology	2	2	117
5	Diabetes	1	1	56

Pertti J. Pentikäinen

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Pharmacodynamics and Safety of a New Calcium Sensitizer, Levosimendan, and Its Metabolites during an Extended Infusion in Patients with Severe Heart Failure Matti Kivikko, Saila Antila, Jaan Eha, The Journal of Clinical Pharmacology	2002	127
Comparative Pharmacokinetics of Lovastatin, Simvastatin and Pravastatin in Humans Pertti J. Pentikäinen, Markku Saraheimo, Jules I. Schwartz, The Journal of Clinical Pharmacology	1992	101
Pharmacokinetics of Levosimendan in Healthy Volunteers and Patients with Congestive Heart Failure Esa-Pekka Sandell, Marja Häyhä, Saila Antila, Journal of Cardiovascular Pharmacology Heart FailureSteady StateOral LevosimendanHealthy VolunteersPharmacology	1995	100
Pharmacokinetics of Levosimendan in Healthy Volunteers and Patients with Congestive Heart Failure Esa-Pekka Sandell, Marja Häyhä, Saila Antila, Journal of Cardiovascular Pharmacology Therapeutic Drug MonitoringHeart FailureSteady StateOral LevosimendanHealthy Volunteers	1995	91
The Effect of Spironolactone on Antipyrine Metabolism in Man David H. Huffman, Don W. Shoeman, Pertti J. Pentikäinen, Pharmacology Molecular PharmacologyAntipyrine MetabolismMedicinePhysiologyIncreased Excretion	1973	70
Pharmacokinetics of levosimendan and its circulating metabolites in patients with heart failure after an extended continuous infusion of levosimendan Saila Antila, Matti Kivikko, Lasse Lehtonen, British Journal of Clinical Pharmacology	2004	68
Diseases and drugs causing prolongation of the QT interval Markku Laakso, Åsa Åberg, J Savola, The American Journal of Cardiology Disease ProgressionNon-communicable DiseasePharmacotherapyMedicineQt Interval	1987	56
Cholesterol Lowering Effect of Metformin in Combined Hyperlipidemia: Placebo Controlled Double Blind Trial Pertti J. Pentikäinen, Erkki Voutilainen, Antti Aro, Annals of Medicine Metabolic SyndromeMetformin ValuesCardiovascular DiseaseCombined HyperlipidemiaMedicine	1990	56
Main results of the losartan versus amlodipine (LOA) study on drug tolerability and psychological general well-being Björn Dahlöf, Lars Lindholm, Shane Carney, Journal of Hypertension	1997	53
Plasma Levels and Excretion of Estrogens in Urine in Chronic Liver Disease Pertti J. Pentikäinen, Leena A. Pentikäinen, Daniel L. Azarnoff, Gastroenterology UrologyHepatologyPlasma LevelsLiver PhysiologyChronic Liver Disease	1975	47

Page 1